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Abstract Effectiveness of immune surveillance of intra-
cellular viruses and bacteria depends upon a functioning
antigen presentation pathway that allows infected cells to
reveal the presence of an intracellular pathogen. The anti-
gen presentation pathway uses virtually all endogenous
polypeptides as a source to produce antigenic peptides that
are eventually chaperoned to the cell surface by MHC class
I molecules. Intriguingly, MHC I molecules present pep-
tides encoded not only in the primary open reading frames
but also those encoded in alternate reading frames. Here,
we review recent studies on the generation of cryptic
pMHC I. We focus on the immunological signiﬁcance of
cryptic pMHC I, and the novel translational mechanisms
that allow production of these antigenic peptides from
unconventional sources.
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Introduction
Nearly all vertebrate cells express molecules of the major
histocompatibility complex class I (MHC) on their surface.
Each MHC I molecule contains a peptide derived from one
of various endogenous proteins. Thus, the peptide reper-
toire presented by MHC I reﬂects the intracellular protein
milieu and, in infected or transformed cells, includes
additional proteins such as those derived from intracellular
pathogens. Because the pMHC I serve as unique ligands for
the CD8
? cytotoxic T cell receptors, the generation of
pMHC I by the antigen presentation pathway allows the
CD8
? T cells to detect and eventually eliminate infected or
transformed cells.
The antigen presentation pathway begins in the cyto-
plasm (Fig. 1)[ 1, 2]. Most polypeptide precursors are
fragmented by the proteasome into proteolytic intermedi-
ates in the cytoplasm. The intermediates are then
transported into the endoplasmic reticulum (ER) by the
TAP heterodimer. Once in the ER, the MHC I molecules
in the peptide-loading complex (PLC) are loaded with
appropriate peptides with the help of ER aminopeptidases
and housekeeping chaperones. After being loaded with the
appropriate peptide cargo, MHC I carry the bound pep-
tides to the cell surface for presentation to CD8
? T cells.
Because neither the MHC I molecules nor the CD8
? T
cells discriminate among sources of precursor polypep-
tides, immune surveillance can use pMHC I that arise
from normal as well as non-conventional translational
mechanisms.
New protein synthesis supplies a signiﬁcant portion of
peptides presented on the cell surface as pMHC I [3, 4].
Indeed, it has been argued that a ribosome-based mecha-
nism may have evolved to use a fraction of newly
translated polypeptides exclusively as substrates for anti-
gen processing and presentation [5]. In addition, evidence
has accumulated showing that non-conventional transla-
tional mechanisms also serve as a unique source of
peptides for presentation by MHC class I [1, 6, 7]. Here, we
review recent immunological and biochemical studies of
non-conventional sources of MHC I ligands that arise
during unexpected ribosome decoding events on endoge-
nous as well as viral mRNAs.
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123Naturally processed cryptic peptide ligands for T cells
Since the original observations of Boon and colleagues
describing presentation of antigenic peptides referred to
as ‘‘peptons’’ that seemed to arise from unexpected
sources [8], the list of cryptic peptides recognized by T
cells has grown considerably (reviewed in [6, 7]. The
examples (Table 1) include peptides that arise from
untranslated regions (UTRs or introns) of the mRNA—
challenging the very deﬁnition of an open reading frame
(ORF)—as well as peptides encoded in alternate trans-
lational reading frames (ARF) and from non-AUG start
codon initiation on both endogenous and viral mRNAs.
That cryptic pMHC I arise from endogenous as well as
virally-encoded mRNAs suggests that immune surveil-
lance has evolved to exploit highly conserved aspects of
protein translation.
The examples listed in Table 1 suggest that while
mammalian ribosomes must carefully select the correct
start codon of the ORF for synthesis of functional proteins
they also promiscuously translate other regions of the
mRNA irrespective of the ORF location for MHC class I
presentation. On one hand, it may be tempting to dismiss
these translational events simply as mistakes without any
physiological relevance. On the other hand, the fact that
cryptic peptides effectively compete with the hundreds of
thousands of other peptides presented by MHC class I on
the cell surface and elicit T cell responses argues that
cryptic peptides are immunologically relevant for immune
surveillance.
Immunological signiﬁcance of cryptic translation
In the last few years, the identiﬁcation of non-conventional
epitopes arising from ARF translation on viral mRNAs has
highlighted the functional signiﬁcance of cryptic epitopes
during immune surveillance (Table 1). In addition to
murine AIDS which was found to elicit protective cyto-
toxic CD8
? T lymphocyte responses (CTLs) towards an
ARF peptide encoded in the LP-BM5 gag gene [9, 10],
simian immunodeﬁciency virus (SIV) mac239-infected
rhesus macaques mounted a strong CTL response towards
an epitope that was translated from the ?2 reading frame
relative to the env ORF [11]. Further, using HLA-B*07
transgenic mice, Cardinaud et al. [12] showed that CTLs
target an HLA-B*07-restricted ARF epitope translated
from the ?2 ORF within the gag gene and that this ARF
epitope was recognized by CTLs in HIV-infected individ-
uals. More recently, Maness et al. [13] have determined
that nearly one-quarter of the anti-SIV CD8
? T cell
responses in SIV-infected rhesus macaques are directed
towards cryptic epitopes generated from ARF translation.
To assess the global impact of these cryptic epitopes for
both immune surveillance and viral evolution, several
groups have used bioinformatic prediction methods to
identify potential non-conventional epitopes in HIV-infec-
ted individuals [14–16]. Berger et al. analyzed HIV gag,
pol, and nef sequences from a cohort of 765 individuals to
identify HLA allele-associated viral polymorphisms.A total
of 64 HLA-associated viral polymorphisms translated in the
?2o r?3 reading frames were identiﬁed. One particular
polymorphism showed that individuals expressing the
HLA-A*03 allele were signiﬁcantly less likely to have
serine at position 241 in the ?2 reading frame of integrase
compared with individuals lacking this HLA type. Indeed,
epitope mapping showed the optimal sequence to be RR9
(RTSKASLER) with serine at position 6 (underlined) which
potently inhibited viral replication in vitro. As predicted
from the identiﬁed polymorphism within this sequence, the
most common escape variant RPR9 (RTSKAPLER) con-
tained proline at position 6 (underlined). Not only was this
sequence translated in an alternate reading frame, but no
upstream in-frame AUG start codons were present. Instead,
a codon normally encoding leucine was identiﬁed as a likely
start site. Bansal et al. also determined HLA-associated
polymorphisms in the six possible translational reading
frames of HIV-1 gag, pol, and nef which include antisense
transcripts. They found both sense- and antisense-encoded
ARF epitopes were immunogenic during primary and
chronic infections and that these ARF epitopes were often
mutated during the ﬁrst year of infection. This observation
is consistent with an important role for ARF epitopes in
immune responses that inhibit viral replication and can thus
select for escape variants.
Fig. 1 Schematic diagram of the MHC class I antigen processing
pathway that culminates in display of peptide bound MHC I on the
cell surface. Most antigenic peptides are derived from polypeptides
synthesized in the cytoplasm by translation of open reading frames
(ORF). However, many other peptides arise as defective ribosomal
polypeptides (DRiPs) by translation of ORF or cryptic reading frames
(RF). The polypeptides undergo proteolysis in the same compartment
and are then transported into the endoplasmic reticulum (ER). In the
ER, many peptides are further trimmed by aminopeptidases and
assembled with the resident MHC molecules. The MHC I molecules
then chaperone the peptides to the cell surface where they serve as
potential ligands for the killer CD8
? T cell repertoire
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123Table 1 Examples of natural sources of cryptic pMHC I
Cell type Peptide source References
Endogenous sources: non-coding mRNA
BALB/c radiation-induced leukemia 50 untranslated region of c-akt oncogene [60]
Human melanoma Region of the MUM-1 gene spanning intron–exon
junction
[61]
Human melanoma Intron of the N-acetyl glucosaminyltransferase V gene [62]
Human melanoma, normal cultured melanocyte cell
line
Intron of gp100 gene [63]
Human melanoma Intron of TRP-2 gene [64]
Human renal cell carcinoma 50-UTR region of VEGF, likely from initiation at CUG,
a non-AUG start codon
[25]
Endogenous sources: alternate reading frame
Human melanoma, normal cultured melanocyte cell
line
Alternate ORF of gp75 [65]
Human squamous cell carcinoma, lung
adenocarcinoma
Alternative ORF of SARC-1 [66]
Human melanoma, breast cancer cells Alternate ORF of NY-ESO-1 [67]
Human melanoma Alternate ORF of CAMEL [68]
Renal cell carcinoma Alternate ORF of the intestinal carboxyl esterase gene,
initiated at ACG
[69]
Human renal cell carcinoma, normal kidney and
liver cells
Alternate ORF of the M-CSF gene [70]
Human melanoma cell lines Alternate RF of BING-4 [31]
Human synovial ﬂuid from a patient with Reiter’s
syndrome
Internal coding sequence with ?1 frameshift (ORF2) of
IL-10
[35]
Mouse melanoma cell lines Alternate RF of human HER-2, human PAP, and mouse
TERT
[32]
Human renal cell carcinoma Alternate RF of the C19orf48 gene [33]
Mouse liver cells transduced with AAV2 Alternate RF of coagulation factor 1X (F9) [18]
Human leukemia cells Alternate RF of the abl gene [71]
Viral sources: alternate reading frame
Murine cell line (L929) infected with vaccinia Alternate ORF of mutant inﬂuenza NP. The authors
found that out-of-frame epitopes were expressed even
when the AUG for the primary ORF was in an
excellent context for translation initiation. The level
of expression of out-of-frame epitopes increased as
the context of the primary AUG worsened
[72]
Cells from mouse infected with LP-BM5 MAIDS
retroviral complex
Alternate ORF of MAIDS gag gene. Mice infected with
MAIDS generated CTL against this epitope
[9]
Human cell line (T1-B7 and Jurkat) infected with
HIV human PBMC
Alternative RF of HIV gag, pol and env genes [12]
Human cell line (HEK293) DNA vaccine with alternate RF of pol gene from HBV,
Alternate RF of OVA
[73]
SIV-infected rhesus macaques Alternate RF of SIV env gene [11]
PBMC, monocyte-derived dendritic cells, and B
cells from rhesus macaques
DNA vaccine/vector encoding a portion of the env ORF
likely through non-AUG initiation
[17]
Human CD4
? T cells from chronically-infected
individuals
Alternate RF of HIV-1 integrase gene likely through a
non-AUG start codon
[15]
SIV-infected rhesus macaques Alternate RF of SIV pol, tat/vpr, env, and env/Rev
genes; some likely through non-AUG initiation
[74]
Endogenous sources: non-AUG initiation
Human B cell acute lymphoblastic leukemia,
Epstein-Barr virus-transformed B cells
HB-1, initiated at CUG codon [75]
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Cardinaud et al. who characterized a mutation within the
HIV-1 gag ARF (QPRSDTHVF, Q9VF) (personal com-
munication). They found that patients eliciting CTL
responses against Q9VF did not contain provirus encoding
this epitope, but rather Q9VF/5 N (QPRSNTHVF), a
parental epitope with a D to N mutation. Apparently, this
point mutation inhibits presentation of Q9VF/5 N by a
proteasome degradation mechanism. This is an interesting
example of how ARF peptides providing a cellular defense
against infection allow viruses to evolve, within a short
period of time, to subvert effectiveness of immune sur-
veillance by CD8
? cytotoxic T cells.
These examples underscore the possibility that vaccine
design could be enhanced by the inclusion of non-con-
ventional epitopes, including ARF epitopes described from
HIV-1. Indeed, Maness et al. [17] show that ARF epitopes
in DNA vaccines elicit a much stronger response in rhesus
macaques than normal infection. However, presentation of
immunogenic peptides from ARFs can also have deleteri-
ous effects as shown by Samulski’s group, where a DNA
cassette being used for human gene therapy trials generated
unexpected ARF polypeptides [18]. The targeting of these
pMHC I by cytotoxic T cells caused a loss of genetically
modiﬁed cells and failure of their therapeutic potential.
Certainly, it is desirable to understand the fundamental
mechanisms which direct non-conventional translation on
both endogenous and viral message in order to harness the
utility and prevent unwanted effects of non-conventional
epitopes.
Mechanisms for producing cryptic peptides
for presentation
Non-conventional epitopes are derived from polypeptide
precursors that serve no obvious function in the cell but are
nevertheless presented on MHC class I molecules. By
deﬁnition, these precursors could be described as DRiPs
(defective ribosomal products), destined for automatic
entry into the MHC class I presentation pathway [19]. If
such precursors were readily available for antigen presen-
tation, they could serve to efﬁciently report the status of the
cell (infected or transformed) to the immune system. This
would be particularly beneﬁcial during viral infection since
many viral proteins have evolved to be extremely stable
[half life (t)[24 h] and recalcitrant to proteasomal
degradation [e.g., EBNA1 from Epstein-Barr virus (EBV)
and LANA1 from Kaposi’s sarcoma-associated herpesvirus
(KHSV)] [20–23]. The different translational mechanisms
for producing cryptic polypeptide precursors could cir-
cumvent the delay in presentation of stable viral proteins
through protein turn-over. Indeed, Cardinaud et al. show
that truncated antigenic precursors are generated when
ribosomes terminate translation of EBNA1 prematurely
[24]. Other mechanisms include translation from non-
coding regions and alternate reading frames of the mRNA
as well as from non-AUG start codons within any region of
the mRNA. The ﬂexibility to use a variety of translation
mechanisms might relieve the bottlenecks of conventional
translation such as when translation initiation factors are
limiting or even missing (Fig. 2).
Translation of ‘‘non-coding’’ mRNA
The recent discovery of an HLA-B*2705 bound peptide
translated from the 50-UTR of VEGF, likely through ini-
tiation at a CUG start codon, suggests cryptic translation
products are novel targets for tumor therapy [25]. This
peptide is abundantly presented by HLA-B*2705 mole-
cules in tumor tissues as a result of VEGF mRNA
overexpression, and draws attention to the existence of
tumor antigens within non-coding regions of the mRNA.
Table 1 continued
Cell type Peptide source References
Human renal cell carcinoma 50-UTR region of VEGF, likely from initiation at CUG,
a non-AUG start codon
[25]
Renal cell carcinoma Alternate ORF of the intestinal carboxyl esterase gene,
initiated at ACG
[69]
Viral sources: non-AUG initiation
PBMC, monocyte-derived dendritic cells, and B
cells from rhesus macaques
DNA vaccine/vector encoding a portion of the env ORF
likely through non-AUG initiation
[17]
Human CD4
? T cells from chronically-infected
individuals
Alternate RF of HIV-1 integrase gene likely through a
non-AUG start codon
[15]
SIV-infected rhesus macaques Alternate RF of SIV pol, tat/vpr, env, and env/Rev
genes; some likely through non-AUG initiation
[74]
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somes are capable of initiating translation upstream or
downstream of the normal ORF start codon (including
introns from unspliced mRNA). These ﬁndings challenge
the model of translation where ribosomes scan for and
initiate only at the ﬁrst AUG start codon of an ORF in a
proper Kozak context [26].
In the conventional model for translation, ribosomes
preloaded with initiator methionine-tRNA (Met-tRNAi
Met),
the only tRNA thought to initiate translation, bind to the 50-
end of the mRNA and scan linearly in the 30 direction for
the start codon. Initiation of protein synthesis is a tightly
regulated step requiring at least ten initiator factors that
comprise more than 26 polypeptides [27] and is the target
of many cellular pathways during normal and stress con-
ditions [28]. How frequently non-coding regions of the
mRNA are translated is presently unknown. The analysis is
made especially difﬁcult by our reliance on current gene
annotations, including the speciﬁed 50- and 30-UTR
sequences. Indeed, construction and sequencing of human
50-UTRs show that many annotated genes are missing on
average 45 bases of the 50-UTR and nearly 30% contain
upstream AUG starts (uAUG), many with a suitable Kozak
context [29, 30]. Given that ribosomes enter the mRNA at
the 50 end, use of uAUGs or non-uAUGs could be an
important source of cryptic epitopes. Accordingly, UTRs
should be considered during epitope discovery, especially
when short uORFs yield precursors that require minimal
processing prior to entry into the antigen presentation
pathway.
Translation of alternate reading frames
More than half the documented non-conventional MHC
class I epitopes arise from ARF translation in a variety of
human diseases such as inﬂuenza virus infections, cancer,
and autoimmunity (Table 1). In addition to initiation at the
primary ORF start codon, ribosomes can also translate the
mRNA in the two other reading frames on both endoge-
nous and viral messages. Furthermore, many ARF epitopes
arise from precursors that are\50 amino acids [12, 31–33],
which should require minimal degradation in the cytosol
prior to entry into the ER and loading onto MHC class I
molecules. A reduced requirement for proteolytic pro-
cessing places many of these ARF epitopes at a kinetic
advantage compared to the hundreds of thousands of pep-
tides that are thought to compete for eventual loading onto
MHC class I molecules either before or after arriving into
the ER.
Several distinct translational mechanisms could account
for the generation of ARF epitopes: (1) initiation codon
read-through, (2) frame-shifting, and (3) re-initiation.
Bullock and Eisenlohr [34] showed that, despite a primary
ORF start codon in an ideal Kozak context, ribosomes
often bypassed this codon and initiated translation further
downstream to generate antigenic precursors. Since this
seminal discovery, many examples have been described for
both endogenous and viral mRNAs where the primary ORF
start codon is bypassed for downstream initiation of cryptic
epitopes (Table 1).
Frame-shifting is a phenomena whereby ribosomes may
initiate at the primary ORF start codon but ‘slip’ either
forward (?1 frame-shift) or backwards (-1 frame-shift)
and continue translation in an alternate reading frame. This
event produces an N-terminal primary ORF polypeptide
fused to a polypeptide decoded from an alternate reading
frame. Indeed, Saulquin et al. [35] showed that ?1 frame-
shifting in the IL-10 mRNA sequence generated a cryptic
epitope derived partly from ORF1 and partly from ORF2.
Likewise, another epitope within the thymidine kinase gene
was generated only when ribosomal frame-shifting occur-
red and was effective in eliciting protective CD8
? T cells
in vivo [36]. While frame-shifting has been best charac-
terized in lower organisms [37], human mitochondrial (mt)
ribosomes undergo frame-shifting at AGA and AGG
codons due to lack of mt-tRNAs that recognize these
codons [38]. These so-called ‘hungry’ codons signal the
ribosome to frame-shift in the -1 direction which high-
lights the possibility that ribosomes on cellular messages
may also be subject to frame-shifting during a reduced
supply of tRNA due to either ﬂuctuations in natural
abundance or reduction in steady-state levels of aminoa-
cylated-tRNAs.
Re-initiation is an additional mechanism that could give
rise to ARF epitopes. This mechanism has been best
characterized from translation of Saccharomyces cerevisiae
transcriptional activator GCN4 whereby amino acid star-
vation-induced phosphorylation of the initiation factor eIF2
Fig. 2 Schematic view of translational products of a typical mRNA
containing untranslated regions (UTR) and the translated open reading
frame (ORF). The polypeptides arise from translation of the ORF
(RF0), or alternate reading frames (RF1 or RF2) by ribosomes
initiating at the conventional AUG or non-conventional CUG codons.
The AUG and the CUG initiation codons can be translated as the
canonical methionine (M) or the leucine (L) residues, respectively.
UAG is a translation termination codon. The ﬁnal peptides presented
by MHC molecules are shown as colored circles
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initiate at the primary GCN4 ORF [39]. Initiation factor
eIF2, recruits initiator Met-tRNAi
Met to the small ribosomal
subunit in a GTP-dependent manner, prior to entry at the
50-end of mRNAs [40]. Different stresses activate cellular
kinases (PKR, PERK, HRI, and GCN2) which phosphor-
ylate Ser51 on the a subunit of eIF2 and limit its
availability for initiation at AUG start codons. Interest-
ingly, in mammalian cells, stress-induced phosphorylation
of eIF2a causes ribosomes to bypass translation of uORFs
and re-initiate at the transcriptional regulator activating
transcription factor, ATF4-coding region [41].
Recently, Ingolia et al. [42] developed an elegant tech-
nique to globally monitor the position of ribosomes as
thousands of mRNAs are translated in budding yeast under
both rich and starvation conditions. Since initiation is a
rate-limiting step of translation, this approach allows a
direct determination of the translational reading frame
utilized by the ribosomes anywhere along an mRNA
sequence. Interestingly, during starvation conditions when
eIF2a phosphorylation is enhanced, ribosome initiation at
non-AUG start codons in uORFs dramatically increased.
This suggests that translation of non-conventional regions
of mRNAs in mammalian cells may also be upregulated
during cellular stress. Interestingly, some viral infections
activate PKR-mediated phosphorylation of eIF2a [43],
which may encourage re-initiation not only at uORFs but
other regions of the mRNA generating additional sources
of non-conventional epitopes.
Non-AUG translation initiation
Initiation at non-AUG start codons on cellular and viral
messages (CUG, ACG, etc.) is another mechanism to
generate non-conventional antigenic peptides whether in
the primary or alternate ORF (Table 1)[ 44]. In the
scanning model of translation, the small ribosomal subunit
containing initiator Met-tRNAi
Met along with eIF4F and a
whole host of initiation factors scans linearly until the ﬁrst
AUG in a good Kozak context (CC(A/G)CCAUGG) is
encountered [26, 45] This mechanism predisposes initia-
tion to commence only with methionine. Even non-AUG
start codons, such as CUG, are believed to be decoded
only with Met-tRNAi
Met through ‘wobble’ interactions
between the codon and anticodon of the tRNA. Interest-
ingly, regulation of the innate immune response through
type-I IFN has recently been shown to be linked to the
phosphorylation state of eIF4E [46]. The precise connec-
tions between translational control and innate immunity
are outside the scope of this review but highlight the
emerging intersection between translational control and
immune regulation [47].
Recently, we showed that the CUG start codon either in
the primary ORF or within a 30-untranslated region (30-
UTR) is a substrate for an unusual alternative translational
mechanism using leucine as the initiating amino acid [48,
49]. To study this mechanism in vivo, Schwab et al. [49]
generated mice with a transgene encoding a cryptic peptide
initiated by CUG in the 30-UTR of a conventional antigenic
peptide ORF. T cell assays were used to detect the CUG/
leucyl-initiated antigen and, despite its low abundance, the
cryptic pMHC I was fully capable of inducing tolerance in
transgenic mice as well as eliciting CD8
? T cell responses
in wild-type mice. This suggests that even low levels of
CUG/leucyl initiation, regardless of the reading frame,
directs the generation of precursors which can efﬁciently
compete for loading onto MHC I molecules. Further, the
existence of a non-competing initiation event with leucine
offers the cell a distinct advantage for antigen presentation
when methionine and/or associated initiation factors are
limiting. To what extent leucine initiation contributes to the
pool of cryptic pMHC I awaits discovery of the set of
proteins translated using the unconventional mechanism of
CUG/leucine initiation, such as human trypsinogen [50].
The only other example of initiation without methionine
is during IRES-mediated translation of the downstream
capsid protein coding sequence of the cricket paralysis
(CrPV) or the Plautia stali intestine viruses [51, 52]. Ini-
tiation at these non-AUG start codons using alanine (GCU)
or glutamine (CAA) residues in mammalian cells suggests
that highly conserved features of the ribosome are ame-
nable to a range of non-canonical initiation events [53]. In
contrast to translation on these viral messages, CUG/leu-
cine initiation is not directed by a speciﬁc sequence or
IRES element [49]. Furthermore, initiation at a CUG start
codon, similar to AUG, was enhanced by the Kozak con-
text [26]. This observation indicates that leucine insertion
occurred during initiation as opposed to a post-translational
modiﬁcation. In contrast, CUG/leucine initiation was
inhibited by insertion of upstream, out-of-frame CUG
codons but not AUG start codons [54], suggesting that a
distinct ribosome initiation mechanism speciﬁcally scans
for and decodes CUG start codons with the alternative
amino acid leucine.
The cellular response to viral infection is often mani-
fested by shut-down of host-translation (reviewed in [55]).
This antiviral translational response can induce phosphor-
ylation of eIF2a and limit initiator Met-tRNAi
Met
recruitment to the ribosome [40], which ultimately favors
translation of viral mRNAs. Interestingly, chemical mim-
icry of the antiviral response using sodium arsenite to
phosphorylate eIF2a showed that while conventional
translation at AUG was inhibited cryptic translation from
the CUG start codon was resistant [54]. This suggests that
during viral infection a switch from AUG/methionine to
1476 S. R. Starck, N. Shastri
123CUG/leucine would continue to supply a source of epitopes
for immune surveillance by the CD8
? T cell repertoire.
Evidence that cryptic pMHC I is generated by a distinct
initiation mechanism was recently investigated by analyz-
ing ribosome initiation complexes at CUG start codons
directly. Starck et al. used a technique called primer
extension inhibition analysis or ‘toeprinting’ to monitor
initiation complex assembly at CUG start codons in a cell-
free extract. This approach showed that ribosome initiation
complexes do assemble at cryptic CUG with up to 1/5th the
efﬁciency of canonical initiation at AUG [56]. Further,
these cryptic CUG initiation complexes were fully depen-
dent on recognition of the mRNA m
7GpppN cap structure
by eIF4E and the Kozak context, which further indicates
that the cryptic translation product arises from a novel
initiation mechanism in contrast to post-translational
alterations of the epitope.
Using a series of protein synthesis inhibitors, Starck
et al. further deﬁned the requirements for cryptic transla-
tion at CUG. For example, both methionine-sulfamide and
edeine, which inhibit initiator Met-tRNAi
Met-eIF2 activity
[57, 58], compromised ribosome assembly at AUG while
CUG complexes were resistant. These data extend the
measurements from Schwab et al. [54] which show eIF2-
independent translation of cryptic pMHC and indicate that
the functional differences are intrinsic to the ribosome
initiation complex. Independently, Yewdell and Nicchitta
[59] have argued in favor of an ‘‘immunoribosome’’
dedicated to the efﬁcient supply of polypeptides for pre-
sentation by MHC I.
The series of inhibitors which distinguish canonical
initiation from cryptic CUG initiation all act within the P
site of the ribosome, the site where initiator Met-tRNAi
Met
assembles for addition of the ﬁrst amino acid [56]. This
suggests that structural features of the ribosome initiation
complex such as a unique initiator tRNA and/or ribosomal
RNA directs CUG initiation. While the precise molecular
mechanism awaits further characterization, we propose that
CUG/leucine initiation increases the complexity of the
proteome especially under certain cellular stress conditions
that inhibit canonical initiation with Met-tRNAi
Met. These
cryptic initiation events would continue to supply an
important source of peptides for antigen presentation dur-
ing cellular stress when conventional translation
mechanisms are subverted.
Conclusions and future perspectives
More than 20 years have elapsed since CD8
? T cells were
discovered to recognize cryptic peptides presented by
MHC class I molecules. Although initially considered a
curiosity, we now know that cryptic peptides can arise from
polypeptides translated from many endogenous and viral
mRNAs. These peptides are immunologically signiﬁcant
and can play a protective role in viral infections. Like the
large fraction of antigenic peptides presented by MHC
class I molecules that are derived from DRiPs, cryptic
peptides arise from a variety of mechanisms also tied to
protein translation. Recent studies have provided tantaliz-
ing hints that ribosomes that carry out the synthesis of
antigenic precursors for cryptic peptides are distinct from
those responsible for conventional translation. We expect
characterization of these novel ribosomes as well as the
pathways that regulate their activity will reveal further
insights into the as yet mysterious sources of antigenic
peptides that make immune surveillance possible.
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